Conti, P

• Vol 35, No 2 (2021) - Article
  Antibodies for COVID-19 - which, when and how long?
  Abstract
• Vol 35, No 2 (2021) - Article
  Monoclonal antibody therapy in COVID-19
  Abstract
• Vol 35, No 3 (2021) - Article
  Anaphylaxis is a rare reaction in COVID-19 vaccination
  Abstract
• Vol 35, No 3 (2021) - Article
  Neurohormonal markers in chronic rhinosinusitis
  Abstract
• Vol 35, No 4 (2021) - Article
  Mast cell virus infection and inflammatory cytokines
  Abstract
• Vol 35, No 1 (2021) - Article
  The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem
  Abstract
• Vol 30, No 2 (2016) - Article
  Endocrinology of the skin: intradermal neuroimmune network, a new frontier
  Abstract
• Vol 31, No 1 (2017) - Article
  Fibromyalgia and bipolar disorder: extent of comorbidity and therapeutic implications
  Abstract
• Vol 31, No 2 (2017) - Article
  Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues
  Abstract
• Vol 35, No 3 (2021) - Article
  Be aware of SARS-CoV-2 spike protein: There is more than meets the eye
  Abstract
• Vol 34, No 1 (2020) - Article
  Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy
  Abstract
• Vol 33, No 5 (2019) - Article
  Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity
  Abstract
• Vol 29, No 1 (2015) - Article
  Can vitamin a mediate immunity and inflammation?
  Abstract
• Vol 29, No 2 (2015) - Article
  CROSSTALK BETWEEN VITAMIN B AND IMMUNITY
  Abstract
• Vol 29, No 2 (2015) - Article
  ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY
  Abstract